BIOPHYTISBIOPHYTISBIOPHYTIS

BIOPHYTIS

No trades
See on Supercharts
Market capitalization
‪3.37 M‬EUR
−0.0326EUR
‪−17.03 M‬EUR
‪970.35 M‬
Beta (1Y)
0.57

About BIOPHYTIS

CEO
Stanislas Veillet
Headquarters
Paris
Founded
2006
ISIN
FR0012816825
FIGI
BBG009J35BW8
Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Its products include Sarconeos (BIO101), which is used to treat sarcopenic obesity and Macuneos (BIO201), which is used to treat dry age-related macular degeneration (AMD). The company was founded by Stanislas Veillet and René Lafont on September 27, 2006 and is headquartered in Paris, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ALBPS is 0.0024 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange BIOPHYTIS stocks are traded under the ticker ALBPS.
BIOPHYTIS is going to release the next earnings report on Oct 29, 2024. Keep track of upcoming events with our Earnings Calendar.
ALBPS stock is 4.35% volatile and has beta coefficient of 0.57. Check out the list of the most volatile stocks — is BIOPHYTIS there?
One year price forecast for BIOPHYTIS has a max estimate of 0.0400 EUR and a min estimate of 0.0400 EUR.
ALBPS earnings for the last quarter are −0.01 EUR per share, whereas the estimation was −0.01 EUR resulting in a 5.55% surprise. The estimated earnings for the next quarter are 0.00 EUR per share. See more details about BIOPHYTIS earnings.
Yes, you can track BIOPHYTIS financials in yearly and quarterly reports right on TradingView.
ALBPS stock has fallen by 11.11% compared to the previous week, the month change is a 20.00% fall, over the last year BIOPHYTIS has showed a 92.94% decrease.
ALBPS net income for the last quarter is ‪−9.26 M‬ EUR, while the quarter before that showed ‪−7.76 M‬ EUR of net income which accounts for −19.29% change. Track more BIOPHYTIS financial stats to get the full picture.
Today BIOPHYTIS has the market capitalization of ‪2.33 M‬, it has increased by 6.23% over the last week.
No, ALBPS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALBPS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOPHYTIS stock right from TradingView charts — choose your broker and connect to your account.
ALBPS reached its all-time high on Aug 5, 2015 with the price of 19.3000 EUR, and its all-time low was 0.0024 EUR and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOPHYTIS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOPHYTIS stock shows the sell signal. See more of BIOPHYTIS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BIOPHYTIS future price: according to them, ALBPS price has a max estimate of 0.04 EUR and a min estimate of 0.04 EUR. Read a more detailed BIOPHYTIS forecast: see what analysts think of BIOPHYTIS and suggest that you do with its stocks.